Загрузка...
Hypopigmentation in an African patient treated with imatinib mesylate: a case report.
Imatinib mesylate (STI 571, Gleevec) is a potent bcr-abl tyrosine kinase inhibitor. It also inhibits c-kit tyrosine kinase. Imatinib mesylate is active in the treatment of cronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It is considered by some authorities to be the standar...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
National Medical Association
2003
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2594583/ https://ncbi.nlm.nih.gov/pubmed/12934870 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|